These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 23429832)

  • 21. Interstitial lung diseases in children: a review.
    Vangveeravong M; Schidlow DV
    J Med Assoc Thai; 1995 Mar; 78(3):145-56. PubMed ID: 7643031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Interstitial lung disease related to systemic connective tissue diseases].
    Fiedorczyk M; Rojewska J; Kowal-Bielecka O; Sierakowski S
    Przegl Lek; 2005; 62(12):1471-4. PubMed ID: 16786776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Demography of paediatric renal care in Europe: organization and delivery.
    Ehrich JH; El Gendi AA; Drukker A; Janda J; Stefanidis C; Verrier-Jones K; Collier J; Katz M
    Nephrol Dial Transplant; 2005 Feb; 20(2):297-305. PubMed ID: 15173377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic options for systemic sclerosis related interstitial lung diseases.
    Mouthon L; Bérezné A; Guillevin L; Valeyre D
    Respir Med; 2010 Jul; 104 Suppl 1():S59-69. PubMed ID: 20630349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis and management of diffuse lung disease in children.
    Vece TJ; Fan LL
    Paediatr Respir Rev; 2011 Dec; 12(4):238-42. PubMed ID: 22018037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interstitial lung disease and idiopathic inflammatory myopathies: progress and pitfalls.
    Labirua A; Lundberg IE
    Curr Opin Rheumatol; 2010 Nov; 22(6):633-8. PubMed ID: 20827201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical networks for ILD: casting light on diffuse lung shadows.
    Harrison NK; Johnson N; Wilsher M
    Thorax; 2010 Jun; 65(6):466-8. PubMed ID: 20522837
    [No Abstract]   [Full Text] [Related]  

  • 28. The pathogenesis of interstitial lung diseases in children.
    Clement A; Henrion-Caude A; Fauroux B
    Paediatr Respir Rev; 2004 Jun; 5(2):94-7. PubMed ID: 15135117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Children's Interstitial and Diffuse Lung Disease. Progress and Future Horizons.
    Deterding RR
    Ann Am Thorac Soc; 2015 Oct; 12(10):1451-7. PubMed ID: 26414005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patients with rare diseases work to jump-start research; advocacy groups create their own tissue banks to aid in drug treatment.
    Marcus AD
    Wall St J (East Ed); 2006 Jul; ():D1, D2. PubMed ID: 16906687
    [No Abstract]   [Full Text] [Related]  

  • 31. Best practices recommendations for chiropractic care for older adults: results of a consensus process.
    Hawk C; Schneider M; Dougherty P; Gleberzon BJ; Killinger LZ
    J Manipulative Physiol Ther; 2010; 33(6):464-73. PubMed ID: 20732584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic predisposition and pathogenetic mechanisms of interstitial lung diseases of unknown origin.
    Verleden GM; du Bois RM; Bouros D; Drent M; Millar A; Müller-Quernheim J; Semenzato G; Johnson S; Sourvino G; Olivier D; Pietinalho A; Xaubet A
    Eur Respir J Suppl; 2001 Sep; 32():17s-29s. PubMed ID: 11816821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroendocrine cell hyperplasia as an unusual form of interstitial lung disease.
    Reyes LJ; Majó J; Perich D; Morell F
    Respir Med; 2007 Aug; 101(8):1840-3. PubMed ID: 17586309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Interstitial lung diseases among patients hospitalized in the Department of Respiratory Medicine in Radom District Hospital during the years 2000-2009].
    Szafrański W
    Pneumonol Alergol Pol; 2012; 80(6):523-32. PubMed ID: 23109204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical interpretation for the pressure-flow relationships in extrinsic allergic alveolitis and in interstitial lung disease pulmonary hypertension patients. Should we care for the lung, the pulmonary artery pressure or both?].
    Lupi-Herrera E; Santos-Martínez LE; Pulido T; Sandoval J
    Arch Cardiol Mex; 2009; 79(2):91-103. PubMed ID: 19722378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence-based medicine for rare diseases: implications for data interpretation and clinical trial design.
    Behera M; Kumar A; Soares HP; Sokol L; Djulbegovic B
    Cancer Control; 2007 Apr; 14(2):160-6. PubMed ID: 17387301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The problems of classification of the occupational interstitial lung diseases, approaches to solving].
    Orlova GP
    Med Tr Prom Ekol; 2013; (8):27-9. PubMed ID: 24340757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pediatric interstitial lung disease revisited.
    Fan LL; Deterding RR; Langston C
    Pediatr Pulmonol; 2004 Nov; 38(5):369-78. PubMed ID: 15376335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New classifications and concepts of pathogenesis and management of diffuse interstitial lung diseases.
    Demedts M; Thomeer M
    Verh K Acad Geneeskd Belg; 2003; 65(6):337-50. PubMed ID: 14964035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis.
    Hellmich B; Flossmann O; Gross WL; Bacon P; Cohen-Tervaert JW; Guillevin L; Jayne D; Mahr A; Merkel PA; Raspe H; Scott DG; Witter J; Yazici H; Luqmani RA
    Ann Rheum Dis; 2007 May; 66(5):605-17. PubMed ID: 17170053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.